Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Statement of Comprehensive Income 

Edwards Lifesciences Corp., consolidated statement of comprehensive income

US$ in thousands

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net income 1,503,100  823,400  1,046,900  722,200  583,600 
Foreign currency translation adjustments (50,100) 32,400  (11,200) (38,600) 97,500 
Unrealized gain (loss) on hedges 57,400  (40,200) (11,100) 40,400  (30,600)
Unrealized pension credits (costs) 11,600  (4,200) (1,900) 600  3,500 
Unrealized gain (loss) on available-for-sale investments (24,100) 6,600  6,300  (3,300) (7,800)
Reclassification of net realized investment loss to earnings 8,600  300  400  2,900  3,100 
Other comprehensive income (loss), net of tax 3,400  (5,100) (17,500) 2,000  65,700 
Comprehensive income 1,506,500  818,300  1,029,400  724,200  649,300 

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Comprehensive income item Description The company
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Edwards Lifesciences Corp. net income decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.
Comprehensive income Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Edwards Lifesciences Corp. comprehensive income decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.